News
SCNI
0.4817
-1.69%
-0.0083
Weekly Report: what happened at SCNI last week (0219-0223)?
Weekly Report · 1d ago
Weekly Report: what happened at SCNI last week (0212-0216)?
Weekly Report · 02/19 09:39
Weekly Report: what happened at SCNI last week (0205-0209)?
Weekly Report · 02/12 09:36
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Societal CDMO (NASDAQ:SCTL) shares moved upwards by 23.4% to $0.57 during Wednesday's pre-market session. Elicio Therapeutics and PepGen also moved upwards. Apollomics shares rose by 19.86% during the session. Losers CytoMed Therapeutic and GRI Bio stock declined by 16.9%.
Benzinga · 02/07 13:06
Weekly Report: what happened at SCNI last week (0129-0202)?
Weekly Report · 02/05 09:39
Scinai Immunotherapeutics files to sell 5.36M ADS for holders
Seeking Alpha · 01/30 21:29
Weekly Report: what happened at SCNI last week (0122-0126)?
Weekly Report · 01/29 09:36
Scinai Immunotherapeutics Ltd.: Correspondence
Press release · 01/25 12:00
Scinai Immunotherapeutics Ltd.: [Amend]Statement of acquisition of beneficial ownership by individuals
Press release · 01/25 00:00
Weekly Report: what happened at SCNI last week (0115-0119)?
Weekly Report · 01/22 09:37
Scinai Immunotherapeutics Ltd.: Report of foreign issuer
Press release · 01/18 18:00
Weekly Report: what happened at SCNI last week (0108-0112)?
Weekly Report · 01/15 09:36
Scinai Immunotherapeutics Ltd.: Report of foreign issuer
Press release · 01/09 20:00
Weekly Report: what happened at SCNI last week (0101-0105)?
Weekly Report · 01/08 09:37
Scinai Immunotherapeutics Ltd.: Report of foreign issuer
Press release · 01/04 22:04
Scinai Immunotherapeutics Ltd.: [Amend]Statement of acquisition of beneficial ownership by individuals
Press release · 01/02 22:01
Scinai Immunotherapeutics Ltd.: Report of foreign issuer
Press release · 01/02 16:00
Scinai Immunotherapeutics Ltd.: Prospectus [Rule 424(b)(3)]
Press release · 01/02 16:00
More
Webull provides a variety of real-time SCNI stock news. You can receive the latest news about Scinai Immunotherapeutics Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About SCNI
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.